Indole derivatives for the treatment of osteoporosis
AssigneeSmith Kline Beecham Corporation
InventorsCarlo Farina, Stefania Gagliardi, Guy Marguerite Marie Gerard Nadler
Life of this patent
Estimating the term…
Loading patent…
AssigneeSmith Kline Beecham Corporation
InventorsCarlo Farina, Stefania Gagliardi, Guy Marguerite Marie Gerard Nadler
Estimating the term…
A compound of formula (I): 1 or a salt thereof, or a solvate thereof, wherein Ra represents a group R5 which is hydrogen, alkyl or optionally substituted aryl and Rb represents a moiety of formula (a): 2 wherein X represents a hydroxy or an alkoxy group wherein the alkyl group may be substituted or unsubstituted or X represents a group NRsRt wherein Rs and Rt each independently represent hydrogen, alkyl, substituted alkyl, optionally substituted alkenyl, optionally substituted aryl, optionally substituted arylalkyl, an optionally substituted heterocyclic group or an optionally substituted heterocyclylalkyl group, or Rs and Rt together with the nitrogen to which they are attached form a heterocyclic group; RI represents an alkyl or a substituted or unsubstituted aryl group; and R2, R3 and R4 each independently represent hydrogen, alkyl, aryl or substituted aryl R6 and R7 each independently represents hydrogen, hydroxy, amino, alkoxy, optionally substituted aryloxy, optionally substituted benzyloxy, alkylamino, dialkylamino, halo, trifluoromethyl, trifluoromethoxy, nitro, alkyl, carboxy, carbalkoxy, carbamoyl, alkylcarbamoyl, or R6 and R7 together represent methylenedioxy, carbonyldioxy or carbonyldiamino; and R8 represents hydrogen, hydroxy, alkanoyl, alkyl, aminoalkyl, hydroxyalkyl, carboxyalkyl, carbalkoxyalkyl, carbamoyl or aminosulphonyl; a process for preparing such a compound, a pharmaceutical composition containing such a compound and the use of such a compound in medicine
A selective inhibitor of the biological activity of human osteoclast cells, providing that such an inhibitor does not include any specific Example disclosed in WO 96/21644.
A compound of formula (I):
A process for the preparation of a compound of formula (I) or a salt thereof or a solvate thereof, which process comprises reacting a compound of formula (II):
24 A pharmaceutical composition comprising a selective inhibitor of the pharmacological activity of human osteoclast cells according to claim 1, and a pharmaceutically acceptable carrier therefor.
Dependencies are inferred from the claim text.